Ignite Creation Date:
2024-05-06 @ 10:49 AM
Last Modification Date:
2024-10-26 @ 12:36 PM
Study NCT ID:
NCT03360851
Status:
TERMINATED
Last Update Posted:
2021-05-21
First Post:
2017-10-27
Brief Title:
DiagNostic Study of Low-dose CT and multipleX PCR on Antibiotic Treatment and Outcome of Community-Acquired Pneumonia
Sponsor:
MJM Bonten
Organization:
UMC Utrecht
Study Overview
Official Title:
DiagNostic Intervention Study of Low-dose CT and multipleX PCR on Antibiotic Treatment and Outcome of Community-Acquired Pneumonia
Status:
TERMINATED
Status Verified Date:
2021-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
COVID-19 pandemic has changed routine diagnostic workup of patients admitted with pneumonia Continuation of the trial was felt to invalidate the study results
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CAP-NEXT
Brief Summary:
Rationale
Uncertainty in the clinical and etiological diagnosis of community-acquired pneumonia CAP often leads to incorrect treatment and unnecessary use of broad-spectrum antibiotics Establishing the clinical diagnosis of CAP is hampered by the suboptimal sensitivity of chest radiograph to detect pulmonary infiltrates 70 Establishing the etiological diagnosis is also hampered mainly because of the inevitable diagnostic delays and low sensitivity of routine microbiological tests There are currently no recommendations for low-dose chest computed tomography low-dose CT or viral and bacterial point-of-care multiplex polymerase chain reaction PoC-PCR in the diagnostic work-up of CAP patients because the data supporting such an approach are lacking
Objective The aim of this study is to determine the added value of low-dose CT and PoC-PCR in the diagnostic workup of patients with CAP hospitalised to non-intensive care unit ICU wards in minimizing selective antibiotic pressure while maintaining patient safety
Study design Cluster-randomised controlled trial with historical control period
Study population Adult patients 18 years old with a clinical diagnosis of CAP requiring hospitalisation to a non-ICU ward
Intervention Intervention arm 1 availability of PoC-PCR during the ER visit intervention arm 2 performing low-dose CT from the ER or at least within 24 hours control arm standard care
Main study parametersendpoints The primary effectiveness outcome is days of therapy of broad-spectrum antibiotics The primary safety outcome on which the sample size is calculated is 90-day all-cause mortality
Nature and extent of the burden and risks associated with participation benefit and group relatedness There are no risks associated with performing the PoC-PCR and the radiation of the low-dose CT is of negligible risk Nasopharyngeal swab collection causes a temporary unpleasant sensation The low-dose CT can reveal unexpected findings which may require additional diagnostic procedures for which the treating physician will use state-of-the-art guidelines Treatment recommendations to de-escalate or stop antibiotic treatment may be beneficial for the individual patient by minimising exposure to antibiotics and improve targeted use of antibiotics Final decisions are always made by the treating physician taking into account all clinical information
Uncertainty in the clinical and etiological diagnosis of community-acquired pneumonia CAP often leads to incorrect treatment and unnecessary use of broad-spectrum antibiotics Establishing the clinical diagnosis of CAP is hampered by the suboptimal sensitivity of chest radiograph to detect pulmonary infiltrates 70 Establishing the etiological diagnosis is also hampered mainly because of the inevitable diagnostic delays and low sensitivity of routine microbiological tests There are currently no recommendations for low-dose chest computed tomography low-dose CT or viral and bacterial point-of-care multiplex polymerase chain reaction PoC-PCR in the diagnostic work-up of CAP patients because the data supporting such an approach are lacking
Objective The aim of this study is to determine the added value of low-dose CT and PoC-PCR in the diagnostic workup of patients with CAP hospitalised to non-intensive care unit ICU wards in minimizing selective antibiotic pressure while maintaining patient safety
Study design Cluster-randomised controlled trial with historical control period
Study population Adult patients 18 years old with a clinical diagnosis of CAP requiring hospitalisation to a non-ICU ward
Intervention Intervention arm 1 availability of PoC-PCR during the ER visit intervention arm 2 performing low-dose CT from the ER or at least within 24 hours control arm standard care
Main study parametersendpoints The primary effectiveness outcome is days of therapy of broad-spectrum antibiotics The primary safety outcome on which the sample size is calculated is 90-day all-cause mortality
Nature and extent of the burden and risks associated with participation benefit and group relatedness There are no risks associated with performing the PoC-PCR and the radiation of the low-dose CT is of negligible risk Nasopharyngeal swab collection causes a temporary unpleasant sensation The low-dose CT can reveal unexpected findings which may require additional diagnostic procedures for which the treating physician will use state-of-the-art guidelines Treatment recommendations to de-escalate or stop antibiotic treatment may be beneficial for the individual patient by minimising exposure to antibiotics and improve targeted use of antibiotics Final decisions are always made by the treating physician taking into account all clinical information
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None